Wells Fargo’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $208K | Buy |
20,833
+20,628
| +10,062% | +$206K | ﹤0.01% | 4358 |
|
|
2025
Q1 | $18K | Buy |
205
+4
| +2% | +$352 | ﹤0.01% | 5286 |
|
|
2024
Q4 | $18.7K | Buy |
201
+61
| +44% | +$5.67K | ﹤0.01% | 5290 |
|
|
2024
Q3 | $10.2K | Sell |
140
-5
| -3% | -$366 | ﹤0.01% | 5388 |
|
|
2024
Q2 | $8.4K | Buy |
145
+49
| +51% | +$2.84K | ﹤0.01% | 5403 |
|
|
2024
Q1 | $99.4K | Buy |
96
+13
| +16% | +$13.5K | ﹤0.01% | 4530 |
|
|
2023
Q4 | $65.9K | Buy |
83
+19
| +30% | +$15.1K | ﹤0.01% | 4741 |
|
|
2023
Q3 | $30.6K | Sell |
64
-56
| -47% | -$26.8K | ﹤0.01% | 5065 |
|
|
2023
Q2 | $72K | Buy |
120
+73
| +155% | +$43.8K | ﹤0.01% | 4955 |
|
|
2023
Q1 | $33K | Buy |
+47
| New | +$33K | ﹤0.01% | 5092 |
|
|
2022
Q4 | – | Sell |
-1
| Closed | – | – | 7123 |
|
|
2022
Q3 | $0 | Sell |
1
-2
| -67% | – | ﹤0.01% | 6307 |
|
|
2022
Q2 | $2K | Sell |
3
-40
| -93% | -$26.7K | ﹤0.01% | 5993 |
|
|
2022
Q1 | $27K | Sell |
43
-85
| -66% | -$53.4K | ﹤0.01% | 5561 |
|
|
2021
Q4 | $52K | Buy |
128
+126
| +6,300% | +$51.2K | ﹤0.01% | 5497 |
|
|
2021
Q3 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 6318 |
|